CA2506238C - Composes derives de chroman et leurs formulations pour utilisation a des fins therapeutiques - Google Patents

Composes derives de chroman et leurs formulations pour utilisation a des fins therapeutiques Download PDF

Info

Publication number
CA2506238C
CA2506238C CA 2506238 CA2506238A CA2506238C CA 2506238 C CA2506238 C CA 2506238C CA 2506238 CA2506238 CA 2506238 CA 2506238 A CA2506238 A CA 2506238A CA 2506238 C CA2506238 C CA 2506238C
Authority
CA
Canada
Prior art keywords
hydrogen
compound
hmc
chroman
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2506238
Other languages
English (en)
Other versions
CA2506238A1 (fr
Inventor
Andrew Heaton
Alan Husband
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lite Strategy Inc
Original Assignee
Mei Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2004315009A external-priority patent/JP4976649B2/ja
Priority claimed from AU2004906363A external-priority patent/AU2004906363A0/en
Application filed by Mei Pharma Inc filed Critical Mei Pharma Inc
Publication of CA2506238A1 publication Critical patent/CA2506238A1/fr
Application granted granted Critical
Publication of CA2506238C publication Critical patent/CA2506238C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2506238 2004-09-21 2005-05-03 Composes derives de chroman et leurs formulations pour utilisation a des fins therapeutiques Expired - Fee Related CA2506238C (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US61129904P 2004-09-21 2004-09-21
US60/611,299 2004-09-21
JP2004315009A JP4976649B2 (ja) 2004-09-21 2004-10-29 化合物
JP2004-315009 2004-10-29
AU2004906363A AU2004906363A0 (en) 2004-11-05 Compounds
AU2004/906,363 2004-11-05

Publications (2)

Publication Number Publication Date
CA2506238A1 CA2506238A1 (fr) 2006-03-21
CA2506238C true CA2506238C (fr) 2014-04-01

Family

ID=36096935

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2506238 Expired - Fee Related CA2506238C (fr) 2004-09-21 2005-05-03 Composes derives de chroman et leurs formulations pour utilisation a des fins therapeutiques

Country Status (1)

Country Link
CA (1) CA2506238C (fr)

Also Published As

Publication number Publication date
CA2506238A1 (fr) 2006-03-21

Similar Documents

Publication Publication Date Title
US8461361B2 (en) Chroman derivatives, medicaments and use in therapy
US9381186B2 (en) Substituted chroman derivatives, medicaments and use in therapy
JP5816868B2 (ja) 化合物
EP1809618B1 (fr) Dérivés de chromane, médicaments et utilisation à des fins thérapeutiques
CA2506238C (fr) Composes derives de chroman et leurs formulations pour utilisation a des fins therapeutiques
AU2005201855B2 (en) Chroman derived compounds and formulations thereof for use in therapy
JP4913056B2 (ja) 置換クロマン誘導体、医薬品、および治療における使用
ES2431045T3 (es) Derivados de cromano, medicamentos y uso terapéutico
IL182042A (en) Chroman derivatives, medicaments and use in therapy
HK1112617B (en) Chroman derivatives, medicaments and use in therapy

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180503